LSSIX
Price
$24.49
Change
-$0.38 (-1.53%)
Updated
Apr 16 closing price
Net Assets
1.94B
VISGX
Price
$66.10
Change
-$0.96 (-1.43%)
Updated
Apr 16 closing price
Net Assets
33.7B
Ad is loading...

LSSIX vs VISGX

Header iconLSSIX vs VISGX Comparison
Open Charts LSSIX vs VISGXBanner chart's image
Loomis Sayles Small Cap Growth Instl
Price$24.49
Change-$0.38 (-1.53%)
VolumeN/A
Net Assets1.94B
Vanguard Small Cap Growth Index I
Price$66.10
Change-$0.96 (-1.43%)
VolumeN/A
Net Assets33.7B
LSSIX vs VISGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LSSIX vs. VISGX commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSSIX is a Buy and VISGX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 33.7B vs. LSSIX (1.94B). VISGX pays higher dividends than LSSIX: VISGX (0.46) vs LSSIX (0.00). LSSIX was incepted earlier than VISGX: LSSIX (28 years) vs VISGX (27 years). LSSIX (0.94) is less costly to investors than VISGX (0.19). VISGX has a lower initial minimum investment than LSSIX: VISGX (3000) vs LSSIX (100000). VISGX annual gain was more profitable for investors over the last year : -1.34 vs. LSSIX (-5.80). VISGX return over 5 years is better than : 44.97 vs. LSSIX (14.50).
LSSIXVISGXLSSIX / VISGX
Total Expense Ratio0.940.19495%
Annual Report Gross Expense Ratio0.940.19495%
Fund Existence28 years27 years-
Gain YTD-14.477-14.78598%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B33.7B6%
Annual Yield % from dividends0.000.46-
Returns for 1 year-5.80-1.34434%
Returns for 3 years-6.820.34-2,008%
Returns for 5 years14.5044.9732%
Returns for 10 years1.7282.002%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFLYY0.810.01
+0.99%
Air France-KLM
GMVHY7.290.03
+0.41%
ENTAIN PLC
PVCT0.10N/A
-0.83%
Provectus Biopharmaceuticals, Inc.
SCBFY27.33-0.31
-1.12%
Standard Chartered PLC
SBGSY46.37-0.62
-1.32%
Schneider Electric SE